Bicycle Therapeutics Stock (NASDAQ: BCYC) stock price, news, charts, stock research, profile.
You can purchase shares of Bicycle Therapeutics (NASDAQ:BCYC) through any online brokerage.
Other companies in Bicycle Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Upstream Bio (NASDAQ:UPB) and Cogent Biosciences (NASDAQ:COGT).
Bicycle Therapeutics has a consensus price target of $39.21.
The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $14.69 last updated December 24, 2024 at 1:51 PM EST.
There are no upcoming dividends for Bicycle Therapeutics.
Bicycle Therapeutics’s Q4 earnings are confirmed for Tuesday, February 18, 2025.
There is no upcoming split for Bicycle Therapeutics.
Bicycle Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.